Chaiyarat, P., Manachevakul, S., & Phopongsin, S. (2026). Targeted Therapy in Advanced Non-Small Cell Lung Cancer (NSCLC): A Comparison of Erlotinib and Osimertinib within the Thai Healthcare System. Journal of Health Policy, Law and Administration, 12(2), 383–394. retrieved from https://so05.tci-thaijo.org/index.php/journal_law/article/view/286578